rs281874712

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong

The NM_033380.3(COL4A5):​c.3206G>T​(p.Gly1069Val) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: not found (cov: 22)

Consequence

COL4A5
NM_033380.3 missense

Scores

10
5
2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: 7.07
Variant links:
Genes affected
COL4A5 (HGNC:2207): (collagen type IV alpha 5 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.886
PP5
Variant X-108626309-G-T is Pathogenic according to our data. Variant chrX-108626309-G-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 24605.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
COL4A5NM_033380.3 linkuse as main transcriptc.3206G>T p.Gly1069Val missense_variant 36/53 ENST00000328300.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
COL4A5ENST00000328300.11 linkuse as main transcriptc.3206G>T p.Gly1069Val missense_variant 36/531 NM_033380.3 P29400-2
COL4A5ENST00000483338.1 linkuse as main transcriptc.2030G>T p.Gly677Val missense_variant 20/201
COL4A5ENST00000361603.7 linkuse as main transcriptc.3206G>T p.Gly1069Val missense_variant 36/512 P1P29400-1
COL4A5ENST00000505728.1 linkuse as main transcriptc.440G>T p.Gly147Val missense_variant 4/53

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
22
Bravo
AF:
0.00000378

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 05, 2022This sequence change replaces glycine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 1069 of the COL4A5 protein (p.Gly1069Val). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Gly1069 amino acid residue in COL4A5. Other variant(s) that disrupt this residue have been observed in individuals with COL4A5-related conditions (PMID: 24304881), which suggests that this may be a clinically significant amino acid residue. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt COL4A5 protein function. ClinVar contains an entry for this variant (Variation ID: 24605). This missense change has been observed in individuals with X-linked recessive COL4A5-related conditions (PMID: 20378821; Invitae). This variant is not present in population databases (gnomAD no frequency). -
X-linked Alport syndrome Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInstitute of Human Genetics Munich, Klinikum Rechts Der Isar, TU MünchenMay 10, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Pathogenic
0.72
D
BayesDel_noAF
Pathogenic
0.80
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.94
.;D;T
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.87
D;D;D
M_CAP
Pathogenic
0.93
D
MetaRNN
Pathogenic
0.89
D;D;D
MetaSVM
Uncertain
0.51
D
MutationAssessor
Pathogenic
3.8
H;H;.
MutationTaster
Benign
1.0
D;D
PrimateAI
Uncertain
0.76
T
PROVEAN
Pathogenic
-5.8
D;D;.
REVEL
Pathogenic
0.87
Sift
Pathogenic
0.0
D;D;.
Sift4G
Uncertain
0.0030
D;D;.
Polyphen
1.0
.;D;D
Vest4
0.84
MutPred
0.51
Gain of sheet (P = 0.0125);Gain of sheet (P = 0.0125);.;
MVP
0.99
MPC
0.37
ClinPred
1.0
D
GERP RS
5.8
Varity_R
0.99
gMVP
1.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.11
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs281874712; hg19: chrX-107869539; COSMIC: COSV100088792; API